Aug 7, 2025 04:05PM
May 12, 2025 04:11PM
Apr 17, 2025 07:02AM
Apr 17, 2025 07:00AM
May 30, 2023 07:03AM
May 30, 2023 07:00AM
May 23, 2023 04:05PM Atea Pharmaceuticals (AVIR) Confirms $5.75/sh + CVR Acquisition Proposal from Tang Capital Partners’ Affiliate, Concentra Biosciences
May 23, 2023 04:05PM
Feb 9, 2018 03:33PM
Feb 9, 2018 03:30PM
Feb 9, 2018 02:29PM
Feb 9, 2018 02:00PM
Feb 9, 2018 02:00PM
Feb 7, 2018 03:23PM Aviragen Therapeutics (AVIR), Vaxart Amend Terms of Merger Agreement to Increase the Value for Aviragen
Feb 7, 2018 03:22PM
Feb 7, 2018 03:22PM
Feb 6, 2018 10:25AM
Feb 6, 2018 10:25AM
Jan 31, 2018 09:00PM
Jan 31, 2018 08:56PM
Jan 31, 2018 06:15PM Aviragen Provides New Information Supporting Vote FOR Vaxart Merger
Jan 31, 2018 06:15PM
Jan 31, 2018 09:00AM
Jan 29, 2018 09:12AM
Jan 26, 2018 04:04PM
Jan 26, 2018 03:59PM
Jan 26, 2018 03:59PM
Jan 24, 2018 02:59PM Aviragen Therapeutics (AVIR) Publishes Letter Asking Shareholders for Support & Vote for Proposed Merger with Vaxart
Jan 24, 2018 02:55PM
Jan 24, 2018 02:55PM
Jan 24, 2018 09:00AM
Jan 11, 2018 07:09PM
Jan 11, 2018 07:09PM
Nov 29, 2017 07:03AM
Nov 29, 2017 07:00AM Aviragen Therapeutics Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of Teslexivir (BTA074) for the Treatment of Condyloma
Nov 2, 2017 07:00AM
Oct 30, 2017 07:02AM
Oct 30, 2017 07:00AM
May 4, 2017 07:00AM
Apr 4, 2017 06:02AM
Apr 4, 2017 06:00AM
Sep 14, 2016 04:01PM Aviragen Therapeutics Reports Fourth Quarter and Fiscal Year 2016 Financial Results
May 5, 2016 04:01PM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All